BioNTech SE (BNTX)
92.72
+0.48
(+0.52%)
USD |
NASDAQ |
May 03, 16:00
94.00
+1.28
(+1.38%)
After-Hours: 20:00
BioNTech Total Long Term Debt (Quarterly): 242.19M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 242.19M |
September 30, 2023 | 213.71M |
June 30, 2023 | 223.54M |
March 31, 2023 | 228.77M |
December 31, 2022 | 227.56M |
September 30, 2022 | 269.31M |
June 30, 2022 | 249.55M |
March 31, 2022 | 207.60M |
December 31, 2021 | 341.36M |
September 30, 2021 | 332.54M |
June 30, 2021 | 305.60M |
Date | Value |
---|---|
March 31, 2021 | 298.46M |
December 31, 2020 | 295.31M |
September 30, 2020 | 206.19M |
June 30, 2020 | 79.05M |
March 31, 2020 | 73.50M |
December 31, 2019 | 5.945M |
September 30, 2019 | 74.19M |
June 30, 2019 | 69.74M |
March 31, 2019 | 0.00 |
December 31, 2018 | 62.02M |
September 30, 2018 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
5.945M
Minimum
Dec 2019
341.36M
Maximum
Dec 2021
207.59M
Average
227.56M
Median
Dec 2022
Total Long Term Debt (Quarterly) Benchmarks
Pfizer Inc | 0.00 |
Moderna Inc | 0.00 |
Autolus Therapeutics PLC | -- |
Novavax Inc | 168.02M |
BioVie Inc | -- |